{"database": "lobbying", "table": "lobbying_activities", "rows": [[2632987, "deb5f848-e932-4b4a-befa-d57d287e9e3f", "2A", "MAGILL ASSOCIATES, LLC", 401103511, "THE LIVINGSTON GROUP ON BEHALF OF INNOVATIVE VACCINE TECHNOLOGIES", 2021, "second_quarter", "BUD", "FY'22 defense appropriation bill for the development of a synthetic vaccine", "Army, Dept of (Other),Defense, Dept of (DOD),HOUSE OF REPRESENTATIVES,SENATE", 30000, null, 0, 0, "2021-07-06T11:12:42.737000-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["2632987"], "units": {}, "query_ms": 0.4722519079223275, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}